Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM · NASDAQ Global Market
+$3.42 today
Vol 1.46M · Avg 0.81M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+55.79%
Period High
$117.62
Period Low
$61.45
Latest
$96.79
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$34.50B
Nuvalent, Inc.
NASDAQ:NUVL
$9.08B
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
$7.31B
Arcellx, Inc.
ACLX
$6.73B
Akero Therapeutics, Inc.
AKRO
$4.50B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$4.16B
uniQure N.V.
NASDAQ:QURE
$2.98B
Relay Therapeutics, Inc.
NASDAQ:RLAY
$2.83B
Stoke Therapeutics, Inc.
NASDAQ:STOK
$1.94B
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
$1.77B
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$1.53B
Ventyx Biosciences, Inc.
VTYX
$1.00B
MeiraGTx Holdings plc
NASDAQ:MGTX
$1.00B
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
$917.57M
Solid Biosciences Inc.
NASDAQ:SLDB
$599.52M
Arvinas, Inc.
NASDAQ:ARVN
$508.43M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$366.34M
Inozyme Pharma, Inc.
INZY
$258.25M
Atrium Therapeutics, Inc.
NASDAQ:RNA
$218.04M
Black Diamond Therapeutics, Inc.
NASDAQ:BDTX
$98.62M
Pliant Therapeutics, Inc.
NASDAQ:PLRX
$72.45M
What is the latest RYTM filing?
The latest filing shown is 8-K dated Jun 15, 2026.
How many recent filings does RYTM have?
Intrinsic Alpha currently shows 20 recent filings for RYTM.
Explore More
Continue the stock analysis
Jump to another research area for this company.